XML 29 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Financial Instruments and Financial Risks
6 Months Ended
Jun. 30, 2021
Financial Instruments and Financial Risk Management [Abstract]  
FINANCIAL INSTRUMENTS AND FINANCIAL RISKS

NOTE 5 - FINANCIAL INSTRUMENTS AND FINANCIAL RISKS:

 

  a.

Fair value disclosure

 

Level 1 financial instruments

 

As of June 30, 2021, the Company had equity marketable securities measured at fair value through profit or loss, which met the level 1 criteria. As of June 30, 2021, equity marketable securities totaled to $337 thousand and are presented under “short-term investments” in the condensed consolidated statements of financial position. As of December 31, 2020, the Company had no financial assets measured at level 1.

 

As of June 30, 2021 and December 31, 2020, the Company had no financial liabilities measured at level 1.

 

Level 2 financial instruments

 

As of June 30, 2021, the Company had debt marketable securities measured at fair value through profit or loss, which met the level 2 criteria. As of June 30, 2021, debt marketable securities totaled to $5,845 thousand and are presented under “short-term investments” in the condensed consolidated statements of financial position. As of December 31, 2020, the Company had no financial assets measured at level 2.

 

As of June 30, 2021 and December 31, 2020, the Company had no financial liabilities measured at level 2 

 

Level 3 financial instruments

 

As of June 30, 2021 and December 31, 2020, the Company had no financial assets measured at level 3.

 

As of June 30, 2021 and December 31, 2020, the Company had several financial liabilities measured at fair value through profit or loss, which met the level 3 criteria. See further information below.

 

  b.

Fair value measurements based on unobservable data (level 3)

 

The following table presents the changes in level 3 instruments for the six-month periods ended June 30, 2021 and June 30, 2020:

 

   Contingent
consideration
   Convertible   debentures   Derivative
financial
instruments
   Total 
   U.S. dollars in thousands 
                 
Balance as of January 1, 2021   1,599    
       -
    1,448    3,047 
Payment of contingent consideration   (915)   
-
    
-
    (915)
Recognition of day 1 loss within profit or loss   
-
    
-
    161    161 
Changes in fair value recognized within profit or loss   (434)   
-
    (56)   (490)
Balance as of June 30, 2021   250    
-
    1,553    1,803 

 

   Contingent
consideration
   Convertible   debentures   Derivative
financial
instruments
   Total 
   U.S. dollars in thousands 
                 
Balance as of January 1, 2020   2,170    7,151    1,637    10,958 
Payment of contingent consideration   (1,600)   
-
    
-
    (1,600)
Repayment of convertible debentures   
-
    (680)   
-
    (680)
Initial recognition of financial liability   
-
    
-
    1,450    1,450 
Conversion to equity or other financial liability   
-
    (4,778)   
-
    (4,778)
Recognition of day 1 loss within profit or loss   
-
    
-
    164    164 
Changes in fair value recognized within profit or loss   430    (1,693)   (1,273)   (2,536)
Balance as of June 30, 2020   1,000    
-
    1,978    2,978 

 

  c.

Fair value of financial assets and financial liabilities measured at amortized cost

 

Assets and liabilities which are not measured on a recurrent basis at fair value are presented at their carrying amount, which approximates their fair value.